| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |